COMPARISON OF POST-OPERATIVE VALUES WITH PRE OPERATIVE VALUES OF CA 15-3 AND ITS PROGNOSTIC VALUE by SEHGAL, CHAHAT et al.
Vol 14, Issue 11, 2021
Online - 2455-3891 
Print - 0974-2441
COMPARISON OF POST-OPERATIVE VALUES WITH PRE OPERATIVE VALUES OF CA 15-3 AND 
ITS PROGNOSTIC VALUE
CHAHAT SEHGAL1, SEEMA1*, MANINDER KAUR1, ASHWANI KUMAR2
1Department of Biochemistry, Government Medical College and Rajindra Hospital, Patiala, Punjab, India. 2Department of Surgery, 
Government Medical College and Rajindra Hospital, Patiala, Punjab, India. Email: seemanaurath@gmail.com
Received: 25 August 2021, Revised and Accepted: 05 October 2021
ABSTRACT
Objective: This study was designed and conducted to establish the relationship of biomarker CA 15-3 levels with tumor load in cases of carcinoma breast.
Methods: Fifty female patients with confirmed diagnosis of breast malignancy were included in the study. CA 15-3 levels were measured before 
surgery and after surgery.
Results: It was found that levels of the biomarker were increased in all the cases; the rise was higher in advance cases of carcinoma. Levels decreased 
after the surgery and this decrease was statistically significant.
Conclusions: It was concluded that levels of CA 15-3 increase in cases of carcinoma breast; higher levels indicate advanced stage and that decrease 
in levels indicate effective treatment.
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INTRODUCTION
Mankind has been trying to decipher the enigma of most dreaded 
diagnosis, malignancy. Lots of headway has been made in the field 
of detection and diagnosis. Definitive treatment of malignancy still 
remains elusive. Concerted efforts have been made to understand 
incidence and distribution of various malignancies, worldwide, and 
region wise.
As of 2020, female breast cancer has become most commonly diagnosed 
malignancy, a spot which was earlier occupied by lung cancer [1]. As 
per National Cancer Registry Programme India report of 2020, breast 
cancer is the most commonly diagnosed malignancy in India [2].
Staging of malignancies have been traditionally done using TNM system. 
American Joint Committee on Cancer has stressed on the importance 
of biomarkers and has included biomarkers in the staging in its eighth 
edition. Biomarkers have been integrated with anatomic definitions [3].
Biomarkers for tumors are found in body tissues such as blood and 
urine. They are either produced by the tumor cells or by the body cells 
in response to the proliferating tumor. Levels of biomarkers increase 
in the presence of malignancies [4]. Biomarker levels are useful in 
evaluating the efficacy of chemotherapy, radiotherapy or surgery, and 
the subsequent disease progression [5].
CA 15-3 has been acknowledged as one of the first circulating factors 
with prognostic value for breast cancer. Monitoring of CA 15-3 can 
be useful to evaluate therapy in patients with advanced breast cancer 
which is not assessable clinically or by radiological procedures [6]. 
Clinical utility of CA 15-3 has been established with evidence and is 
recommended for use in practice [7]. It is also useful in monitoring 
response to therapy [8].
Aim
CA 15-3 has been established as biomarker of diagnostic value in 
breast cancer, as well as to evaluate the response to various treatment 
modalities. To further establish role of CA 15-3 in assessing response to 
treatment, it was decided to compare pre op levels of CA 15-3 with post-
operative levels. Surgery is the surest technique to reduce tumor load of 
the body, by removal of primary tumor as well as sentinel lymph nodes.
MATERIALS AND METHODS
Fifty female patients with confirmed diagnosis of carcinoma breast 
were included in the study. These patients were scheduled to undergo 
surgery for removal of primary tumor and axillary clearance of lymph 
nodes. Patients were explained the study and consent was obtained. 
Patients with history of other malignancies apart from carcinoma 
breast and those with liver disease were excluded from the study. 
Serum values of CA 15-3 were determined in these patients before 
and after the surgery. Pre-operative and post-operative serum levels 
of CA 15-3 were compared statistically using paired t-test in SPSS 
software.
OBSERVATION AND RESULTS
Age-wise distribution of patients included in the study (n=50) is shown 
in Table1.
Breast cancer has been diagnosed in almost every age group of adult 
females. In the present study, maximum number of patients was in the 
age group of 41–50 years.
Patients were grouped as per the staging of breast cancer. Stage-wise 
distribution of patients is shown in Table 2.
52% of the cases (n=26) were in Stage III of the disease. Mean pre-
operative levels of serum CA 15-3 in various stage groups of the disease 
are depicted in Table 3.
Mean values of CA 15-3 increased with advancing stage of the disease. 
It was minimum in Stage I cases and maximum in Stage III patients. 
Comparison and statistical analysis of pre-operative and post-operative 
levels of CA 15-3 is shown in Table 4.
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There was statistically significant decrease in mean CA 15-3 levels in 
the post-operative period where tumor load was decreased surgically.
DISCUSSION
The present study was conducted at Government Medical College and 
Rajindra Hospital Patiala, India. This study has established that serum 
levels of CA 15-3 increase in cases of carcinoma breast. The rise in levels 
of the biomarker corresponds with the stage of disease, higher levels 
are found in more advanced stages. Levels decreased significantly after 
surgical reduction of tumor mass.
Hashim in his study concluded that levels of CA 15-3 levels increase in 
cases of carcinoma breast. This increase is directly related to advancing 
stage of disease. Level of CA 15-3 can be used as prognostic tool as high 
levels indicate advanced stage [9]. Findings of the present study are 
also on the same lines. Levels were increased in patients of carcinoma 
breast. Levels increased with advancing stage.
Fejzic et al. conducted a study CA 15-3 levels in cases of breast cancer and 
compared the levels between cases with and without metastases [10]. 
They found significant correlation between CA 15-3 levels and presence 
of metastases and dissemination of disease. Biomarker levels were also 
found to be higher in patients of Stage III in the present study. Khan 
et al. compared levels of CA 15-3 in patients of breast cancer, before 
and after surgery [11]. Levels decreased significantly after the surgery. 
They suggested that post-operative levels compared to pre-operative 
levels, can be an important tool. If the post-operative levels increase, it 
indicates recurrence. Findings of the present study are also on the same 
lines. CA 15-3 levels decreased significantly after surgery.
Gupta et al. in their study on prognostic value of CA 15-3 in breast 
cancer noted that the post-treatment levels were significantly lower 
than pre-treatment levels [12]. They also concluded that higher levels 
are associated with poor prognosis. These findings are in concurrence 
with the findings of present study. Elevated pre-treatment levels 
indicate disseminated disease.
Khushk et al. in their study concluded that post-operative value of CA 
15-3 significantly decreased after surgery [13]. Comparison of pre- and 
post-operative levels may determine the prognosis and can help in 
formulating optimal patient care regime. Results of the present study 
concur with this study. Popat et al. in their study concluded that CA 
15-3 is an important prognostic tool and is important for measuring 
therapeutic efficacy in breast cancer cases [14]. Findings of the present 
study agree with this study.
CONCLUSIONS
Role of biomarkers in staging of malignancy has been accepted and is 
being widely used. New markers are being identified and evaluated 
clinically. CA 13-5 has been identified as an important biomarker 
in cases of breast carcinoma. Levels of CA 15-3 have been included 
in TNM staging of malignancy of breast. The levels correlate very 
well with tumor load and metastases. Efficacy of treatment can be 
evaluated by measuring serial serum levels of this biomarker. Initial 
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Table 1: Age‑wise distribution



















Table 4: Comparison of Pre‑operative and Post‑operative Levels 
of CA 15‑3
Levels Mean±SD t‑value p‑value Significance
Pre-operative 60.49±23.6 11.97 <0.0001 Extremely 
SignificantPost-operative 16.88±10.34
